m003002801001.pdf 1.75 MB
Prolactin (PRL) is associated with lactation, and also plays an important role in the development and progression of breast cancer (BC). PRL exerts its effects via its receptor, the PRL-receptor (PRLR), so it is beneficial to study the distribution and alteration in expression of PRLR in order to elucidate the biologic effects of PRL on BC. In 84 BCs, PRLR expression was examined by an immunohistochemical technique. PRLR immunoreactivity was detected mainly in the cytoplasm. And the overall positive rate (cut-off > 10%) was 71% (60/84), while invasive BC showed a significantly higher positive rate (75%, 57/76) than non-invasive BC (38%, 3/8) (p=0.0264). The PRLR expression showed no correlation with age, primary tumor, nodal involvement, distant metastasis, or clinical stage; however, it was significantly correlated with estrogen receptor (ER) expression (p=0.0361), especially in invasive BC (p=0.0098), but not with the progesterone receptor (PgR) expression or HER-2 expression. PRLR was highly expressed in IDC ( invasive ductal carcinoma) and correlated with ER expression, suggesting that PRL and PRLR may play important roles in the development and progression of ER (+) BC.
Shimane journal of medical science
Shimane University Faculty of Medicine